GenoFocus, Inc. (KOSDAQ: 187420)
South Korea
· Delayed Price · Currency is KRW
4,245.00
+40.00 (0.95%)
Dec 20, 2024, 9:00 AM KST
GenoFocus Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 1,045 | -2,950 | -12,968 | -6,817 | -12,217 | -5,757 | Upgrade
|
Depreciation & Amortization | 4,640 | 4,640 | 4,442 | 3,739 | 2,241 | 2,010 | Upgrade
|
Loss (Gain) From Sale of Assets | 211.99 | 211.99 | 7.43 | 108.57 | 196.06 | 138.67 | Upgrade
|
Asset Writedown & Restructuring Costs | 1,833 | 1,833 | - | 0.02 | 3,654 | 2,008 | Upgrade
|
Loss (Gain) From Sale of Investments | 2,047 | 2,047 | 1,572 | 619.8 | -1,153 | 138.49 | Upgrade
|
Stock-Based Compensation | 215.64 | 215.64 | 81.73 | 103 | 75.19 | 170.42 | Upgrade
|
Provision & Write-off of Bad Debts | -12.46 | -12.46 | 100.54 | -6.03 | 30.31 | -4.25 | Upgrade
|
Other Operating Activities | -7,119 | -11,464 | 5,410 | 2,564 | 5,108 | 815.09 | Upgrade
|
Change in Accounts Receivable | 1,685 | 1,685 | -2,627 | -712.06 | 2,011 | -550.94 | Upgrade
|
Change in Inventory | 75.66 | 75.66 | -876.63 | -733.16 | -1,579 | -654.41 | Upgrade
|
Change in Accounts Payable | 49.9 | 49.9 | -150.47 | -1,430 | -1,926 | 766.8 | Upgrade
|
Change in Other Net Operating Assets | -2,866 | -1,147 | 297.11 | 173.52 | 1,107 | 752.77 | Upgrade
|
Operating Cash Flow | 1,805 | -4,815 | -4,711 | -2,390 | -2,452 | -167.5 | Upgrade
|
Capital Expenditures | -478.48 | -1,212 | -4,021 | -8,712 | -14,330 | -8,430 | Upgrade
|
Sale of Property, Plant & Equipment | 14,340 | 14,340 | 32.18 | - | 64.41 | 11.8 | Upgrade
|
Sale (Purchase) of Intangibles | -85.83 | -120.09 | -298.89 | -317.6 | -1,282 | -1,961 | Upgrade
|
Investment in Securities | 12,826 | 24,023 | -9,475 | 3,301 | -11,003 | -3,235 | Upgrade
|
Other Investing Activities | 1,081 | 981.93 | 653.49 | -878.88 | 1,068 | -205.91 | Upgrade
|
Investing Cash Flow | 27,672 | 38,012 | -13,109 | -6,930 | -25,394 | -14,007 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | - | 7,000 | Upgrade
|
Long-Term Debt Issued | - | 1,000 | 31,000 | - | 37,990 | 19,380 | Upgrade
|
Total Debt Issued | 3,440 | 1,000 | 31,000 | - | 37,990 | 26,380 | Upgrade
|
Short-Term Debt Repaid | - | -500 | - | - | - | -2,000 | Upgrade
|
Long-Term Debt Repaid | - | -15,710 | -11,536 | -546.2 | -8,701 | -474.65 | Upgrade
|
Total Debt Repaid | -30,243 | -16,210 | -11,536 | -546.2 | -8,701 | -2,475 | Upgrade
|
Net Debt Issued (Repaid) | -26,803 | -15,210 | 19,464 | -546.2 | 29,289 | 23,905 | Upgrade
|
Issuance of Common Stock | - | - | 76.34 | 198.47 | 838.65 | 597.56 | Upgrade
|
Other Financing Activities | -2,067 | -6,090 | -435.05 | 312 | 1.83 | - | Upgrade
|
Financing Cash Flow | -28,869 | -21,300 | 22,905 | -35.73 | 30,130 | 24,503 | Upgrade
|
Foreign Exchange Rate Adjustments | -270.42 | -20.73 | -217.17 | 168.57 | -7.16 | -48.38 | Upgrade
|
Net Cash Flow | 337.41 | 11,876 | 4,867 | -9,188 | 2,276 | 10,280 | Upgrade
|
Free Cash Flow | 1,327 | -6,028 | -8,732 | -11,102 | -16,782 | -8,598 | Upgrade
|
Free Cash Flow Margin | 3.81% | -22.32% | -31.41% | -42.91% | -89.41% | -57.54% | Upgrade
|
Free Cash Flow Per Share | 57.68 | -266.63 | -387.97 | -494.72 | -762.85 | -397.98 | Upgrade
|
Cash Interest Paid | 1,242 | 1,228 | 685.83 | 496.24 | 96.98 | 139.9 | Upgrade
|
Cash Income Tax Paid | - | 258.71 | 109.84 | 38.61 | -8.67 | -68.45 | Upgrade
|
Levered Free Cash Flow | -12,098 | -22,116 | -7,397 | -6,249 | -8,514 | -10,209 | Upgrade
|
Unlevered Free Cash Flow | -9,293 | -18,675 | -3,442 | -3,773 | -7,207 | -10,054 | Upgrade
|
Change in Net Working Capital | 13,905 | 16,139 | -303.21 | -3,887 | -9,093 | -109.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.